National guideline for the management of balanitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001446:Balanitis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D002177:Candidiasis / Q000188:drug therapy; D002944:Circumcision, Male; D016358:Contact Tracing; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D010412:Penile Neoplasms / Q000175:diagnosis*; D010413:Penis / Q000382:microbiology / Q000473:pathology; D011230:Precancerous Conditions / Q000175:diagnosis*; D012749:Sexually Transmitted Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D006854:Hydrocortisone